Suzanne K Whitmore1, Xinjian Zhang, Allan W Taylor, Janet M Blair. 1. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. swhitmore@cdc.gov
Abstract
OBJECTIVE: Although perinatal HIV infections are declining in the United States, there is no single source of nationally representative data available to estimate the number of infants born to HIV-infected women in the United States and its dependencies. This study determines the total number of births to HIV-positive women in the United States and 5 dependent areas in 2006. STUDY DESIGN: Diagnosed stage 1 or 2 HIV disease in the United States were based on reported data from 39 areas that conducted confidential name-based HIV case reporting and stage 3 HIV from all areas in the United States. A zero-inflated Poisson model was used to estimate the number of women aged 13-44 years living with diagnosed stage 1 or 2 HIV disease in the United States. The number of undiagnosed HIV-infected women (stage 1 or 2) of childbearing age was estimated from the number of reported Stage 3 HIV (ie, AIDS) cases using a back-calculation method. RESULTS: An estimated 115,200 women aged 13-44 years were living with stage 1 or 2 HIV disease in 2006. A total of 56,200 women were living with diagnosed stage 3 disease. The estimated number of births to all women living with HIV disease (diagnosed or undiagnosed) was 8700 [95% Confidence Interval (CI): 8400 to 8800] in 2006. CONCLUSIONS: The number of infants born to HIV-infected women in 2006 was approximately 30% greater than the number of such births (6075-6422) in 2000. This increase highlights the need to continue and strengthen efforts to prevent perinatal HIV transmission in the United States.
OBJECTIVE: Although perinatal HIV infections are declining in the United States, there is no single source of nationally representative data available to estimate the number of infants born to HIV-infectedwomen in the United States and its dependencies. This study determines the total number of births to HIV-positive women in the United States and 5 dependent areas in 2006. STUDY DESIGN: Diagnosed stage 1 or 2 HIV disease in the United States were based on reported data from 39 areas that conducted confidential name-based HIV case reporting and stage 3 HIV from all areas in the United States. A zero-inflated Poisson model was used to estimate the number of women aged 13-44 years living with diagnosed stage 1 or 2 HIV disease in the United States. The number of undiagnosed HIV-infectedwomen (stage 1 or 2) of childbearing age was estimated from the number of reported Stage 3 HIV (ie, AIDS) cases using a back-calculation method. RESULTS: An estimated 115,200 women aged 13-44 years were living with stage 1 or 2 HIV disease in 2006. A total of 56,200 women were living with diagnosed stage 3 disease. The estimated number of births to all women living with HIV disease (diagnosed or undiagnosed) was 8700 [95% Confidence Interval (CI): 8400 to 8800] in 2006. CONCLUSIONS: The number of infants born to HIV-infectedwomen in 2006 was approximately 30% greater than the number of such births (6075-6422) in 2000. This increase highlights the need to continue and strengthen efforts to prevent perinatal HIV transmission in the United States.
Authors: W Todd Cade; Gautam K Singh; Mark R Holland; Dominic N Reeds; E Turner Overton; Nancy Cibulka; Karen Bahow; Rachel Presti; Andrea Stephens; Alison G Cahill Journal: Clin Nutr ESPEN Date: 2015-08-01
Authors: Mary Jo Trepka; Soumyadeep Mukherjee; Consuelo Beck-Sagué; Lorene M Maddox; Kristopher P Fennie; Diana M Sheehan; Maithri Prabhakar; Dan Thompson; Spencer Lieb Journal: South Med J Date: 2017-02 Impact factor: 0.954
Authors: Kathleen M Malee; Claude A Mellins; Yanling Huo; Katherine Tassiopoulos; Renee Smith; Patricia A Sirois; Susannah M Allison; Deborah Kacanek; Suad Kapetanovic; Paige L Williams; Mitzie L Grant; Daniel Marullo; Angela A Aidala Journal: J Acquir Immune Defic Syndr Date: 2014-04-15 Impact factor: 3.731
Authors: Allan W Taylor; Steven R Nesheim; Xinjian Zhang; Ruiguang Song; Lauren F FitzHarris; Margaret A Lampe; Paul J Weidle; Patricia Sweeney Journal: JAMA Pediatr Date: 2017-05-01 Impact factor: 16.193
Authors: Kathryn Rough; Katherine Tassiopoulos; Deborah Kacanek; Raymond Griner; Ram Yogev; Kenneth C Rich; George R Seage Journal: AIDS Date: 2015-01-02 Impact factor: 4.177
Authors: Andrew C Voetsch; James D Heffelfinger; Juliet Yonek; Pragna Patel; Steven F Ethridge; Gretchen W Torres; Margaret A Lampe; Bernard M Branson Journal: Public Health Rep Date: 2012 Sep-Oct Impact factor: 2.792
Authors: Sarah K Himes; Karl B Scheidweiler; Katherine Tassiopoulos; Deborah Kacanek; Rohan Hazra; Kenneth Rich; Marilyn A Huestis Journal: Anal Chem Date: 2013-01-14 Impact factor: 6.986